Next 10 |
home / stock / ofix / ofix articles
U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday. Shares of Acuity Brands, Inc. (NYSE: AYI) rose sharply Tuesd...
U.S. stock futures traded lower this morning, with the Dow Jones futures falling more than 50 points on Monday. Shares of Alaska Air Group, Inc. (N...
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is in...
NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an investigation of Orthofix Medical I...
SAN FRANCISCO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Orthofix Medical Inc. (NASDAQ:OFIX) investors who suffered substantial loss...
SAN FRANCISCO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Orthofix Medical Inc. (NASDAQ:OFIX) investors who suffered substantial loss...
If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner...
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigati...
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or...
News, Short Squeeze, Breakout and More Instantly...
Orthofix Medical Inc. Company Name:
OFIX Stock Symbol:
NASDAQ Market:
2024-03-24 17:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Lucas Vitale has joined the company in the newly created role of Chief People and Business Operations Officer. This press release features multimedia. View the full release here: htt...
Recent Highlights Fourth quarter 2023 net sales of $200.4 million, an increase of 64% on a reported basis and 7% on a pro forma constant currency basis Bone Growth Therapies net sales growth of 15% for the fourth quarter of 2023, marking four consecutive quarters with doub...